YOU ARE HERE:
Starting treatment news
page  of 18
 
Headline
Date
  Many patients diagnosed with HIV today will have normal life expectancies, European studies find
22.02.10
  Treatment drive in British Columbia produces modest declines in diagnoses and viral loads
19.02.10
  Immune restoration in DART study: late start means low CD4 count for years
19.02.10
  One-quarter died on HIV treatment waiting list in South Africa's Free State province
19.02.10
  ACTG 5202: No significant difference in time to failure between Kivexa and Truvada in patients with lower viral loads when paired with efavirenz or atazanavir
18.02.10
  Even very low levels of pre-existing resistance increase risk of efavirenz failure
10.02.10
  HIV treatment responses in everyday care matching clinical trial levels
09.02.10
  Genetic marker predicts fat loss due to d4T in Thai patients
26.01.10
  Adherence partners give short-term boost, but no long-term benefit, in Nigerian study
26.01.10
  Subtle changes in immune system soon after HIV infection show who may benefit from earlier treatment
21.01.10
  Low quality of life associated with poorer survival for patients taking HIV treatment
05.01.10
  Starting HIV treatment reduces risk of death from all causes; additional benefits if treatment started sooner
05.01.10
  New resistance becoming rarer as more patients achieve undetectable HIV viral load
05.01.10
  Full results of DART lab monitoring study published
09.12.09
  US guidelines now favour treatment at CD4 cell counts between 350 and 500; above 500 not ruled out
01.12.09
  WHO recommends earlier treatment and phase-out of d4T
30.11.09
  New EACS guidelines address co-morbidities and diseases of age
16.11.09
  Protease inhibitor monotherapy as a maintenance regimen: are we edging towards acceptance?
16.11.09
  Cost-effective ways to reduce loss to follow-up in ART programmes identified
28.10.09
  FDA committee recommends approval of maraviroc for first-line treatment in US
09.10.09

page  of 18